Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 19, 2021

View Archived Issues

YAP/TEAD expression defines distinct vulnerabilities in binary pan-cancer groups

Phase II topline data show efficacy of MS-1819 plus PERT in severe exocrine pancreatic insufficiency

DSG3-CAART cells safe in second cohort of DesCAARTes phase I trial

Brexpiprazole does not meet primary endpoint in borderline personality disorder trial

Assembly Biosciences to advance anti-HBV agent ABI-4334 to the clinic

Eisai describes new compounds for malaria

Roche discloses new antibacterials

Phenex Pharmaceuticals presents new AhR antagonists

New anti-MDR1 antibodies discovered by Kenjockety Biotechnology

Green light for UB-421 phase II studies in Taiwan and China for HIV

TCF7L2 gene variants linked to thoracic aortic aneurysm

APVO-436 may benefit patients with AML and MDS, first-in-human data suggest

First patient enrolled in trial on sirolimus drug-eluting balloon for erectile dysfunction

Viral-trapping icosahedral shells devised as broad-spectrum antiviral platform

TT-00420 enters phase I/II trial for advanced solid tumors

"Not just the flu" holds for SARS-CoV-2 long-term effects, too

Well Marker Bio starts phase I study of WM-S1-030 for solid tumors

COM-902 derivative AZD-2936 enters the clinic for non-small cell lung cancer

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...